Analysis shows metabolic reprogramming affects macrophage polarization and Treg cells in immune thrombocytopenia, indicating potential for new treatments.
Key Points
Lysophosphatidylcholine treatment reduced IL-10 in macrophages, disrupting immune balance and promoting Treg cell differentiation.
In vitro experiments revealed modulation of macrophage polarization and phagocytosis, with LPC enhancing M1 macrophage functions.
Glycerophospholipid metabolism was confirmed as a significant pathway altered in immune thrombocytopenia patients compared to healthy controls.
Combination therapy with dexamethasone and atorvastatin effectively restored metabolic balance and immune function in ITP mouse models.